In summary, our study provides for the first time that TRIM66 promoted the proliferation and metastasis via TGF-β signaling pathway, and inhibited cell apoptosis via down-regulating p53 expression in osteosarcoma cells. The gene discussed is TGFB1; the disease is osteosarcoma.